CCR2 and fatty liver disease: Myeloid/macrophage-specific KO models such as IKK-β or CCR2 that impair inflammatory responses in Kupffer cells show attenuation of hepatic insulin resistance in the setting of high-fat feeding, despite the full development of hepatic steatosis (11, 66).